Kintsugi

Kintsugi is developing novel voice biomarker software to detect signs of depression and anxiety from short clips of free form speech. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI Companies to Watch in 2022, Kintsugi helps to close mental health care gaps across risk-bearing health systems, ultimately saving time and lives.